Literature DB >> 16924110

Direct stimulation of T lymphocytes by immunosomes: virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules.

Sophia V Derdak1, Hans J Kueng, Victoria M Leb, Alina Neunkirchner, Klaus G Schmetterer, Edith Bielek, Otto Majdic, Walter Knapp, Brian Seed, Winfried F Pickl.   

Abstract

Many infectious viruses coevolved with the vertebrate immune system. During the assembly of enveloped viruses, lipid ordered domains of the host cell plasma membrane, called lipid rafts, frequently function as a natural meeting point for viral proteins. The role of lipid rafts in the organization of complex combinations of immune receptors during antigen presentation and T cell signaling is widely recognized. In our studies, we determined whether lipid rafts, virus budding, and molecular interactions during T cell activation could be brought into a novel context to create artificial antigen-presenting particles. We show here that cell-free virus-like particles (VLP) expressing a surrogate TCR/CD3 ligand (OKT3scFv) and the costimulator CD80 polyclonally activate human T cells independently of accessory cells. VLP expressing the glycoprotein epitope 33-41 of the lymphocytic choriomeningitis virus in the context of H-2D(b) activate and expand naïve, antigen-specific CD8(+) T lymphocytes and differentiate them into cytotoxic effector cells. Efficient targeting of T cell ligands to lipid rafts and ultimately to VLP is achieved by C-terminal introduction of glycosyl phosphatidyl inositol acceptor sequences, replacing transmembrane and intracellular domains. In this work, basic functions of immunostimulatory molecules meet virus biology and translate into a reductionist antigen-specific T lymphocyte-stimulating vehicle, which we refer to as immunosomes. A large variety of agonistic and antagonistic accessory molecules on genuine antigen-presenting cells may complicate the predictable manipulation of T cells as well as the analysis of selected receptor combinations, making immunosomes potentially useful reagents for such purposes in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924110      PMCID: PMC1559767          DOI: 10.1073/pnas.0602283103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Antigen decoding by T lymphocytes: from synapses to fate determination.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

2.  Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes.

Authors:  Clotilde Théry; Livine Duban; Elodie Segura; Philippe Véron; Olivier Lantz; Sebastian Amigorena
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

3.  Lipid rafts and pseudotyping.

Authors:  W F Pickl; F X Pimentel-Muiños; B Seed
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Cell adhesion and polarity during immune interactions.

Authors:  María C Montoya; David Sancho; Miguel Vicente-Manzanares; Francisco Sánchez-Madrid
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

Review 5.  Exosomes: composition, biogenesis and function.

Authors:  Clotilde Théry; Laurence Zitvogel; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2002-08       Impact factor: 53.106

6.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

7.  Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.

Authors:  J B Latouche; M Sadelain
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

Review 8.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

9.  Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.

Authors:  Waldemar Popik; Timothy M Alce; Wei-Chun Au
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules.

Authors:  Inkyu Hwang; Xuefei Shen; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

View more
  28 in total

1.  A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.

Authors:  Aisha N Hasan; Wouter J Kollen; Deepa Trivedi; Annamalai Selvakumar; Bo Dupont; Michel Sadelain; Richard J O'Reilly
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

Review 2.  Artificial antigen-presenting cells for use in adoptive immunotherapy.

Authors:  Cameron J Turtle; Stanley R Riddell
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

Review 3.  Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.

Authors:  Hunter McFall-Boegeman; Xuefei Huang
Journal:  Expert Rev Vaccines       Date:  2022-01-24       Impact factor: 5.217

4.  Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions.

Authors:  Hans J Kueng; Calin Manta; Daniela Haiderer; Victoria M Leb; Klaus G Schmetterer; Alina Neunkirchner; Ruth A Byrne; Clemens Scheinecker; Peter Steinberger; Brian Seed; Winfried F Pickl
Journal:  FASEB J       Date:  2010-01-07       Impact factor: 5.191

5.  A model for targeting colon carcinoma cells using single-chain variable fragments anchored on virus-like particles via glycosyl phosphatidylinositol anchor.

Authors:  Vipin Kumar Deo; Megumi Yui; Jahangir Alam; Masahito Yamazaki; Tatsuya Kato; Enoch Y Park
Journal:  Pharm Res       Date:  2014-02-26       Impact factor: 4.200

6.  General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.

Authors:  Hans J Kueng; Victoria M Leb; Daniela Haiderer; Graça Raposo; Clotilde Thery; Sophia V Derdak; Klaus G Schmetterer; Alina Neunkirchner; Christian Sillaber; Brian Seed; Winfried F Pickl
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

Review 7.  Gene and virotherapy for hematological malignancies.

Authors:  Evidio Domingo-Musibay; Masato Yamamoto
Journal:  Int J Hematol       Date:  2016-06-11       Impact factor: 2.490

8.  Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules.

Authors:  Kathy Situ; Bernadette Anne Chua; Song Yi Bae; Aaron Samuel Meyer; Kouki Morizono
Journal:  Virology       Date:  2018-10-02       Impact factor: 3.616

9.  B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction.

Authors:  Judith Leitner; Christoph Klauser; Winfried F Pickl; Johannes Stöckl; Otto Majdic; Anaïs F Bardet; David P Kreil; Chen Dong; Tomohide Yamazaki; Gerhard Zlabinger; Katharina Pfistershammer; Peter Steinberger
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

10.  The capacity of the TNF family members 4-1BBL, OX40L, CD70, GITRL, CD30L and LIGHT to costimulate human T cells.

Authors:  Johanna Kober; Judith Leitner; Christoph Klauser; Ramona Woitek; Otto Majdic; Johannes Stöckl; Dietmar Herndler-Brandstetter; Beatrix Grubeck-Loebenstein; Birgit M Reipert; Winfried F Pickl; Katharina Pfistershammer; Peter Steinberger
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.